Effect of Adenosine Triphosphate-Sensitive Potassium Channel Inhibitors on Coronary Metabolic Vasodilation

Trends in Cardiovascular Medicine

Volumn 17, Issue 2, 2007, Pages 63-68

  Farouque, H M Omar ^a,b,c,d   Meredith, Ian T ^a,b,c,d  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CATECHOLAMINE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; INSULIN; SULFONYLUREA; TOLBUTAMIDE;

BLOOD VESSEL TONE; CELL ACTIVITY; CELL MEMBRANE POTENTIAL; CELL METABOLISM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; EXPERIMENTAL STUDY; HEART MUSCLE METABOLISM; HUMAN; HYPEREMIA; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VASCULAR SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CORONARY DISEASE; CORONARY VESSELS; HUMANS; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; VASODILATION;

EID: 33846833652     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2006.12.003     Document Type: Review

References (61)

1. Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [published erratum appears in Lancet 1999 Aug 14;354:602]. Lancet 352 (1998) 837-853
2. Anonymous. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359 (2002) 1269-1275
3. Aronow W., and Ahn C. Incidence of new coronary events in older persons with diabetes mellitus and prior myocardial infarction treated with sulfonylureas, insulin, metformin, and diet alone. Am J Cardiol 88 (2001) 556-557
4. Ashcroft S., and Aschcroft F. Properties and function of ATP-sensitive K-channels. Cell Signal 2 (1990) 197-214
5. Aversano T., Ouyang P., Silverman H., et al. Effect of blockade of the ATP-sensitive potassium channel on metabolic coronary vasodilation in the dog. Pharmacology 47 (1993) 360-368
6. Baukrowitz T., Schulte U., Oliver D., et al. PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science 282 (1998) 1141-1144
7. Beech D., Zhang H., Nakao K., et al. K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol 110 (1993) 573-582
8. Brady P., Al-Suwaidi J., Kopecky S., and Terzic A. Sulfonylureas and mortality in diabetic patients after myocardial infarction. Circulation 97 (1998) 709-710
9. Brayden J. Potassium channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 23 (1996) 1069-1076
10. Clement J., Kunjilwar K., Gonzalez G., et al. Association and stoichiometry of K(ATP) channel subunits. Neuron 18 (1997) 827-838
11. Coppack S., Lant A., McIntosh C., and Rodgers A. Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus. Br J Clin Pharmacol 29 (1990) 673-684
12. Daut J., Maier-Rudolph W., Von Beckerath N., et al. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247 (1990) 1341-1344
13. Davis T., Parsons R., Broadhurst R., et al. Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment. Diabetes Care 21 (1998) 637-640
14. Dean P. Electrical activity in pancreatic islet cells. Nature 219 (1968) 389-390
15. Duncker D., Oei H., Hu F., et al. Role of K(ATP)(+) channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine. Am J Physiol Heart Circ Physiol 280 (2001) H22-H33
16. Duncker D., van Zon N., Altman J., et al. Role of K+ ATP channels in coronary vasodilation during exercise. Circulation 88 (1993) 1245-1253
17. Duncker D., van Zon N., Ishibashi Y., and Bache R. Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. J Clin Invest 97 (1996) 996-1009
18. Duncker D., van Zon N., Pavek T., et al. Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade. J Clin Invest 95 (1995) 285-295
19. Farouque H., Worthley S., Meredith I., et al. Effect of ATP-sensitive potassium channel inhibition on coronary metabolic vasodilation in humans. Arterioscler Thromb Vasc Biol 24 (2004) 905-910
20. Farouque H., Worthley S., Meredith I., et al. Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans. Circ Res 90 (2002) 231-236
21. Feigl E. Coronary physiology. Physiol Rev 63 (1983) 1-205
22. Findlay I. Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle. J Pharmacol Exp Ther 262 (1992) 71-79
23. Garratt K., Brady P., Hassinger N., et al. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33 (1999) 119-124
24. Gollasch M., Bychkov R., Ried C., et al. Pinacidil relaxes porcine and human coronary arteries by activating ATP-dependent potassium channels in smooth muscle cells. J Pharmacol Exp Ther 275 (1995) 681-692
25. Gollasch M., Ried C., Bychkov R., et al. K+ currents in human coronary artery vascular smooth muscle cells. Circ Res 78 (1996) 676-688
26. Gribble F., Tucker S., and Ashcroft F. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol 504 Pt 1 (1997) 35-45
27. Gribble F., Tucker S., Seino S., and Ashcroft F. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes 47 (1998) 1412-1418
28. Henquin J. Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia 18 (1980) 151-160
29. Imamura Y., Tomoike H., Narishige T., et al. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol 263 (1992) H399-H404
30. Ishibashi Y., Duncker D., Zhang J., and Bache R. ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 82 (1998) 346-359
31. Jackson W. Potassium channels and regulation of the microcirculation. Microcirculation 5 (1998) 85-90
32. Jollis J., Simpson Jr. R., Cascio W., et al. Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction. Am Heart J 138 (1999) S376-S380
33. Katsuda Y., Egashira K., Ueno H., et al. Glibenclamide, a selective inhibitor of ATP-sensitive K+ channels, attenuates metabolic coronary vasodilatation induced by pacing tachycardia in dogs. Circulation 92 (1995) 511-517
34. Keung E., and Li Q. Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes. J Clin Invest 88 (1991) 1772-1777
35. Klamann A., Sarfert P., Launhardt V., et al. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide). Eur Heart J 21 (2000) 220-229
36. Lawrence C., Proks P., Rodrigo G., et al. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells. Diabetologia 44 (2001) 1019-1025
37. Lederer W., and Nichols C. Nucleotide modulation of the activity of rat heart ATP-sensitive K+ channels in isolated membrane patches. J Physiol 419 (1989) 193-211
38. Liu G., Hanley P., Ray J., et al. Long-chain acyl-coenzyme A esters and fatty acids directly link metabolism to K(ATP) channels in the heart. Circ Res 88 (2001) 918-924
39. Marcus M., Chilian W., Kanatsuka H., et al. Understanding the coronary circulation through studies at the microvascular level. Circulation 82 (1990) 1-7
40. Meinert C., Knatterud G., Prout T., and Klimt C. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 19 Suppl (1970) 789-830
41. Melchert P., Duncker D., Traverse J., and Bache R. Role of K(+)(ATP) channels and adenosine in regulation of coronary blood flow in the hypertrophied left ventricle. Am J Physiol 277 (1999) H617-H625
42. Merkus D., Houweling B., Van Vliet M., and Duncker D. Contribution of KATP+ channels to coronary vasomotor tone regulation is enhanced in exercising swine with a recent myocardial infarction. Am J Physiol 288 (2005) H1306-H1313
43. Minamino T., Kitakaze M., Node K., et al. Inhibition of nitric oxide synthesis increases adenosine production via an extracellular pathway through activation of protein kinase C. Circulation 96 (1997) 1586-1592
44. Mukamal K., Nesto R., Cohen M., et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 24 (2001) 1422-1427
45. Muller J., Davis M., and Chilian W. Integrated regulation of pressure and flow in the coronary microcirculation. Cardiovasc Res 32 (1996) 668-678
46. Narishige T., Egashira K., Akatsuka Y., et al. Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs. Am J Physiol 266 (1994) H84-H92
47. Nelson M., and Quayle J. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268 (1995) C799-C822
48. O'Keefe J., Blackstone E., Sergeant P., and McCallister B. The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery. Eur Heart J 19 (1998) 1696-1703
49. Pogatsa G., Koltai M., Jermendy G., et al. The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patients. Acta Med Hung 49 (1992) 39-51
50. Reffelmann T., Klues H., Hanrath P., and Schwarz E. Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease. Heart 87 (2002) 54-60
51. Richmond K., Tune J., Gorman M., and Feigl E. Role of K+ ATP channels in local metabolic coronary vasodilation. Am J Physiol 277 (1999) H2115-H2123
52. Richmond K., Tune J., Gorman M., and Feigl E. Role of K(ATP)(+) channels and adenosine in the control of coronary blood flow during exercise. J Appl Physiol 89 (2000) 529-536
53. Rytter L., Troelsen S., and Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 8 (1985) 230-234
54. Samaha F., Heineman F., Ince C., et al. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol 262 (1992) C1220-C1227
55. Sato T., Sasaki N., Seharasyeon J., et al. Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection. Circulation 101 (2000) 2418-2423
56. Song D., and Ashcroft F. Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels. Br J Pharmacol 133 (2001) 193-199
57. Sturgess N., Ashford M., Cook D., and Hales C. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 2 (1985) 474-475
58. Tune J., Richmond K., Gorman M., and Feigl E. K(ATP)(+) channels, nitric oxide, and adenosine are not required for local metabolic coronary vasodilation. Am J Physiol 280 (2001) H868-H875
59. Vivaudou M., and Forestier C. Modification by protons of frog skeletal muscle KATP channels: effects on ion conduction and nucleotide inhibition. J Physiol 486 (1995) 629-645
60. Weih M., Amberger N., Wegener S., et al. Sulfonylurea drugs do not influence initial stroke severity and in-hospital outcome in stroke patients with diabetes. Stroke 32 (2001) 2029-2203
61. + channel. J Physiol 499 (1997) 715-720